Your browser doesn't support javascript.
loading
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
Reid, Michael J A; Arinaminpathy, Nimalan; Bloom, Amy; Bloom, Barry R; Boehme, Catharina; Chaisson, Richard; Chin, Daniel P; Churchyard, Gavin; Cox, Helen; Ditiu, Lucica; Dybul, Mark; Farrar, Jeremy; Fauci, Anthony S; Fekadu, Endalkachew; Fujiwara, Paula I; Hallett, Timothy B; Hanson, Christy L; Harrington, Mark; Herbert, Nick; Hopewell, Philip C; Ikeda, Chieko; Jamison, Dean T; Khan, Aamir J; Koek, Irene; Krishnan, Nalini; Motsoaledi, Aaron; Pai, Madhukar; Raviglione, Mario C; Sharman, Almaz; Small, Peter M; Swaminathan, Soumya; Temesgen, Zelalem; Vassall, Anna; Venkatesan, Nandita; van Weezenbeek, Kitty; Yamey, Gavin; Agins, Bruce D; Alexandru, Sofia; Andrews, Jason R; Beyeler, Naomi; Bivol, Stela; Brigden, Grania; Cattamanchi, Adithya; Cazabon, Danielle; Crudu, Valeriu; Daftary, Amrita; Dewan, Puneet; Doepel, Laurie K; Eisinger, Robert W; Fan, Victoria.
Afiliación
  • Reid MJA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu.
  • Arinaminpathy N; School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
  • Bloom A; Tuberculosis Division, United States Agency for International Development, Washington, DC, USA.
  • Bloom BR; Department of Global Health and Population, Harvard University, Cambridge, MA, USA.
  • Boehme C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Chaisson R; Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA.
  • Chin DP; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Churchyard G; The Aurum Institute, Johannesburg, South Africa.
  • Cox H; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Ditiu L; Stop TB Partnership, Geneva, Switzerland.
  • Dybul M; Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA.
  • Farrar J; The Wellcome Trust, London, UK.
  • Fauci AS; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
  • Fekadu E; Volunteer Health Services, Addis Ababa, Ethiopia.
  • Fujiwara PI; Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Hallett TB; School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
  • Hanson CL; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Harrington M; Treatment Action Group, New York, NY, USA.
  • Herbert N; Global TB Caucus, Houses of Parliament, London, UK.
  • Hopewell PC; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Ikeda C; Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan.
  • Jamison DT; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Khan AJ; Interactive Research & Development, Karachi, Pakistan.
  • Koek I; Global Health Bureau, United States Agency for International Development, Washington, DC, USA.
  • Krishnan N; Resource Group for Education and Advocacy for Community Health, Chennai, India.
  • Motsoaledi A; South African National Department of Health, Pretoria, South Africa.
  • Pai M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.
  • Raviglione MC; University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland.
  • Sharman A; Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan.
  • Small PM; Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
  • Swaminathan S; WHO, Geneva, Switzerland.
  • Temesgen Z; Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA.
  • Vassall A; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.
  • Venkatesan N; The Economic Times, Mumbai, India.
  • van Weezenbeek K; KNCV Tuberculosis Foundation, The Haag, Netherlands.
  • Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Agins BD; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
  • Alexandru S; Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova.
  • Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.
  • Beyeler N; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Bivol S; Center for Health Policies and Studies, Chisinau, Moldova.
  • Brigden G; Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Cattamanchi A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Cazabon D; McGill International TB Center, McGill University, Montreal, QC, Canada.
  • Crudu V; Center for Health Policies and Studies, Chisinau, Moldova.
  • Daftary A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.
  • Dewan P; Bill & Melinda Gates Foundation, New Delhi, India.
  • Doepel LK; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
  • Eisinger RW; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
  • Fan V; T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Manoa, HI, USA.
Lancet ; 393(10178): 1331-1384, 2019 Mar 30.
Article en En | MEDLINE | ID: mdl-30904263
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de la Atención de Salud / Investigación / Tuberculosis Pulmonar / Salud Global Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de la Atención de Salud / Investigación / Tuberculosis Pulmonar / Salud Global Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido